Back to Search Start Over

Incidence of inpatient cases with mental disorders due to use of cannabinoids in Germany: a nationwide evaluation.

Authors :
Gahr, Maximilian
Ziller, Julia
Keller, Ferdinand
Muche, Rainer
Preuss, Ulrich W
Schönfeldt-Lecuona, Carlos
Source :
European Journal of Public Health; Apr2022, Vol. 32 Issue 2, p239-245, 7p
Publication Year :
2022

Abstract

Background Quantitative (e.g. increasing recreational cannabinoid use) and qualitative (e.g. increasing availability and use of synthetic cannabinoids and cannabis preparations with increased tetrahydrocannabinol content) changes in cannabinoid use may be associated with changes in the prevalence of cannabinoid-related mental and behavioural disorders and, accordingly, changes in the need for medical care. We aimed to investigate if there are changes in the number of inpatient cases (ICs) due to cannabinoid-related disorders in Germany. Methods Data were obtained from the Federal Statistical Office of Germany (Destatis) and comprised type and number of hospital main diagnoses (according to ICD-10) of all ICs in Germany in the period 2000–18. Linear trend analysis of absolute and relative annual frequencies (AFs) of ICs with diagnoses related to the use of cannabinoids (DRUCs), and, as controls, alcohol-related psychiatric disorders and schizophrenia-spectrum disorders was performed. Results Absolute AFs of ICs with DRUCs increased statistically significantly (P <0.0001, trend analysis) in Germany between 2000 and 2018 and corresponding relative AFs increased considerably (4.8-fold increase when comparing 2000 and 2018). Specifically, absolute AFs of ICs with cannabinoid intoxications (P <0.0001), harmful use (P =0.0005), dependence syndrome (P < 0.0001), withdrawal state (P <0.0001), psychotic disorders (P < 0.0001) and residual and late-onset psychotic disorder (P <0.0001) statistically significantly increased. Absolute AFs of schizophrenia-spectrum disorders slightly, but statistically significantly decreased (P =0.008), and alcohol dependence did not statistically significantly change (P =0.844). Conclusions Our evaluation demonstrates increasing numbers of ICs with mental and behavioural disorders due to use of cannabinoids in Germany and emphasizes the need for adequate prevention of such disorders. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
11011262
Volume :
32
Issue :
2
Database :
Complementary Index
Journal :
European Journal of Public Health
Publication Type :
Academic Journal
Accession number :
156110176
Full Text :
https://doi.org/10.1093/eurpub/ckab207